About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
SMC accepts azelaic acid (Finacea 15% gel) for topical treatment of papulopustular rosacea
Source:
Scottish Medicines Consortium (SMC)
Date published:
09/05/2007 00:00
Summary
by:
Anonymous
The SMC has advised NHS Boards and Area Drug and Therapeutic Committees that azelaic acid 15% gel (Finacea) is accepted for use within NHS Scotland for the topical treatment of papulopustular rosacea.
About this library entry
Category:
13.6.1 Topical preparations for acne
|
Dermatology
|
Scottish Medicines Consortium
NeLM
area:
Evidence
>
Drug Specific Reviews
Link
Preview your comment
Add new comment
Comment text:
Comments
There are no comments yet. You could be the first!
You must be Logged In to comment.
Printer Friendly Version
Related evidence
13.6.1 Topical preparations for acne
16/02/2010
Primary Care Briefing: Epiduo for the treatment of acne
14/08/2007
Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials
02/05/2007
Clindamycin 1% and benzoyl peroxide 5% gel (Duac® once daily gel) - Mild to moderate acne vulgaris - Full submission
Dermatology
15/05/2012
SMC accepts etanercept (Enbrel®) for restricted use in children and adolescents with psoriasis
12/04/2012
DTB: Management of simple insect bites: where's the evidence?
28/02/2012
Saline irrigation for the management of skin extravasation injury in neonates
Back